BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamanaka K, Fuhlbrigge RC, Mizutani H, Kupper TS. Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma. Arch Dermatol Res 2010;302:453-9. [PMID: 20111968 DOI: 10.1007/s00403-009-1023-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Tsuda K, Yamanaka K, Kondo M, Matsubara K, Sasaki R, Tomimoto H, Gabazza EC, Mizutani H. Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity. PLoS One 2012;7:e51819. [PMID: 23251632 DOI: 10.1371/journal.pone.0051819] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
2 Cedeno-Laurent F, Watanabe R, Teague JE, Kupper TS, Clark RA, Dimitroff CJ. Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma. Blood 2012;119:3534-8. [PMID: 22383798 DOI: 10.1182/blood-2011-12-396457] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
3 Memon SA, Sportès C, Flomerfelt FA, Gress RE, Hakim FT. Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood. J Immunol Methods 2012;375:84-92. [PMID: 21986106 DOI: 10.1016/j.jim.2011.09.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
4 Phillips T, Devata S, Wilcox RA. Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders. J Immunother Cancer 2016;4:95. [PMID: 28031823 DOI: 10.1186/s40425-016-0201-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
5 Durgin JS, Weiner DM, Wysocka M, Rook AH. The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication. J Am Acad Dermatol 2021;84:587-95. [PMID: 33352267 DOI: 10.1016/j.jaad.2020.12.027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fozza C, Corda G, Virdis P, Contini S, Barraqueddu F, Galleu A, Isoni A, Cossu A, Dore F, Careddu MG, Bonfigli S, Giannico B, Longinotti M. Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma. Eur J Haematol 2015;94:298-309. [DOI: 10.1111/ejh.12417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
7 Fozza C, Longinotti M. T-cell receptor repertoire usage in hematologic malignancies. Crit Rev Oncol Hematol. 2012;Dec 5; Epub ahead of print. [PMID: 23219015 DOI: 10.1016/j.critrevonc.2012.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
8 Olsen EA, Rook AH, Zic J, Kim Y, Porcu P, Querfeld C, Wood G, Demierre M, Pittelkow M, Wilson LD, Pinter-brown L, Advani R, Parker S, Kim EJ, Junkins-hopkins JM, Foss F, Cacchio P, Duvic M. Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). Journal of the American Academy of Dermatology 2011;64:352-404. [DOI: 10.1016/j.jaad.2010.08.037] [Cited by in Crossref: 117] [Cited by in F6Publishing: 81] [Article Influence: 11.7] [Reference Citation Analysis]
9 Fozza C, Barraqueddu F, Corda G, Contini S, Virdis P, Dore F, Bonfigli S, Longinotti M. Study of the T-cell receptor repertoire by CDR3 spectratyping. J Immunol Methods 2017;440:1-11. [PMID: 27823906 DOI: 10.1016/j.jim.2016.11.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]